Value of P16INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients With Resectable Non-Small Cell Lung Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0652
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prognosis of Non-Small-Cell Lung Cancer in Patients With Idiopathic Pulmonary Fibrosis

Scientific Reports
Multidisciplinary
2019English

Impact of Lymph Node Management on Resectable Non-Small Cell Lung Cancer Patients

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Cigarette Smoking and P16INK4α Gene Promoter Hypermethylation in Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2011English

The Expression and Promoter Hypermethylation Status of MGMT, RASSF1A in Gastric Cancer

World Journal of Cancer Research
2014English

Prognosis of Patients With Stages I and II Non–Small Cell Lung Cancer With Nodal Micrometastases

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Prognostic Impact of CD8 and Programmed Death-Ligand 1 Expression in Patients With Resectable Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Transcriptional Silencing of Secreted Frizzled Related Protein 1 (SFRP1) by Promoter Hypermethylation in Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Gender Differences and Smoking Affect the Prognosis of Patients With Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy